Results 1 to 10 of about 582,560 (129)
Risk stratification for malignant upgrade in breast atypical hyperplasia: a Korean multi-institutional analysis from academic hospitals [PDF]
Korean Journal of Clinical OncologyPurpose Atypical hyperplasia (AH) management remains controversial due to variable malignant disease progression rates. While Western studies report 10% to 25% upgrade rates, data from Asian populations, particularly from referral academic centers, are ...
Hyobin Kim +10 more
doaj +2 more sources
Cancer Treatment and Research Communications, 2021 Introduction: Several ongoing trials are currently investigating the feasibility and non-inferiority of active surveillance for managing low-risk DCIS.
Michael Co, Andrea Lee, Ava Kwong
doaj +1 more source
Breast, 2022 Background and aim: The natural history of ductal carcinoma in situ (DCIS) is poorly understood. The aim of this cohort study was to determine the outcomes of women who had no surgery for screen-detected DCIS in the 6 months following diagnosis. Methods:
Anthony J. Maxwell +16 more
doaj +1 more source
Autophagy and cancer: Basic mechanisms and inhibitor development
Cancer Science, Volume 114, Issue 7, Page 2699-2708, July 2023., 2023 Autophagy is closely related to cancer, working as either a promoter or suppressor. In this review, we briefly summarize the basic mechanisms of autophagy and describe the complicated roles of autophagy in cancer. Moreover, we summarize the clinical trials of autophagy inhibitors targeting cancer and the development of more specific autophagy ...
Yutaro Hama +2 more
wiley +1 more source
Intraductal Papillary Carcinoma of the Breast: A Case Presentation [PDF]
, 2021 Intraductal papillary carcinoma, also known as papillary ductal carcinoma in situ, forms part of a heterogeneous group of breast lesions, the reported incidence rates are very low and occurs in 27.7/100,000 in women, although the percentage of mortality ...
Larrea Lara, Felipe Antonio +4 more
core +1 more source
Ductal carcinoma in situ diagnosed using an ultrasound-guided 14-gauge core needle biopsy of breast masses: can underestimation be predicted preoperatively? [PDF]
Ultrasonography, 2014 Purpose: This study was designed to determine the rate of ductal carcinoma in situ (DCIS) underestimation diagnosed after an ultrasound-guided 14-gauge core needle biopsy (US-14G- CNB) of breast masses and to compare the clinical and imaging ...
Sung Hee Park +3 more
doaj +1 more source
Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways [PDF]
, 2014 Intraductal papillary neoplasms of the bile duct are still poorly characterized regarding (1) their molecular alterations during the development to invasive carcinomas, (2) their subtype stratification and (3) their biological behavior.
Kim-Fuchs, Corina +15 more
core +2 more sources
Intraductal carcinoma of the prostate is not a diagnostic entity [PDF]
, 2021 We have read with interest the recent debate between Drs Varma and Epstein regarding the grading of intraductal carcinoma of the prostate.$^{1}$ Unfortunately, the arguments as presented do little to abate the confusion surrounding this so-called ...
Kench, James +41 more
core +1 more source
Revista Brasileira de Ginecologia e Obstetrícia, 2006 OBJETIVOS: avaliar os aspectos clínicos, radiológicos, anátomo-patológicos e terapêuticos de uma série de casos de carcinoma ductal in situ (CDIS) da mama de pacientes atendidos em três hospitais públicos de Belo Horizonte (MG).
Marcio de Almeida Salles +3 more
doaj +1 more source
Asian Journal of Surgery, 2020 Summary: Background: Atypical ductal hyperplasia (ADH) is known to be associated with underlying malignant breast conditions. Previous studies have shown that up to 40% of ADH found in core needle biopsy of the breasts had undiagnosed malignant lesions ...
Michael Co, Tony Shek, Ava Kwong
doaj +1 more source